Defective hematopoietic differentiation of immune aplastic anemia patient-derived iPSCs
Abstract In acquired immune aplastic anemia (AA), pathogenic cytotoxic Th1 cells are activated and expanded, driving an immune response against the hematopoietic stem and progenitor cells (HSPCs) that provokes cell depletion and causes bone marrow failure. However, additional HSPC defects may contri...
Main Authors: | Maria Florencia Tellechea, Flávia S. Donaires, Vinícius S. de Carvalho, Bárbara A. Santana, Fernanda B. da Silva, Raissa S. Tristão, Lílian F. Moreira, Aline F. de Souza, Yordanka M. Armenteros, Lygia V. Pereira, Rodrigo T. Calado |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-04-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-04850-5 |
Similar Items
-
THPO gene variants in patients with acquired aplastic anemia
by: Pedro Henrique Padilha, et al.
Published: (2018-10-01) -
IN VIVO EFFECTS OF ELTROMBOPAG ON THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN APLASTIC ANAEMIA
by: B.Q. Oliveira, et al.
Published: (2020-11-01) -
iPSCs are safe!
by: Hualong Yan, et al.
Published: (2017-05-01) -
ENGRAFTMENT POTENTIAL OF CD34+ CELLS FROM SEVERE APLASTIC ANEMIA PATIENTS EXPANDED WITH UM171
by: BS Telho, et al.
Published: (2021-10-01) -
THE ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA
by: Brigitte Strahm
Published: (2023-12-01)